Annual Cash & Cash Equivalents
$1.97 B
-$639.68 M-24.50%
31 December 2023
Summary:
Rentokil Initial annual cash & cash equivalents is currently $1.97 billion, with the most recent change of -$639.68 million (-24.50%) on 31 December 2023. During the last 3 years, it has fallen by -$676.98 million (-25.57%). RTO annual cash & cash equivalents is now -25.57% below its all-time high of $2.65 billion, reached on 01 December 2020.RTO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$1.97 B
-$1.43 M-0.07%
30 June 2024
Summary:
Rentokil Initial quarterly cash and cash equivalents is currently $1.97 billion, with the most recent change of -$1.43 million (-0.07%) on 30 June 2024. Over the past year, it has increased by +$180.76 million (+10.11%). RTO quarterly cash and cash equivalents is now -31.52% below its all-time high of $2.88 billion, reached on 30 June 2022.RTO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RTO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.5% | +10.1% |
| 3 y3 years | -25.6% | -8.9% |
| 5 y5 years | +28.6% | +28.5% |
RTO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -25.6% | +120.9% | -31.5% | +120.8% |
| 5 y | 5 years | -25.6% | +1729.3% | -31.5% | +245.8% |
| alltime | all time | -25.6% | >+9999.0% | -31.5% | +1728.0% |
Rentokil Initial Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $1.97 B(-0.1%) |
| Dec 2023 | $1.97 B(-24.5%) | $1.97 B(+10.2%) |
| June 2023 | - | $1.79 B(-31.5%) |
| Dec 2022 | $2.61 B(+192.6%) | $2.61 B(-9.2%) |
| June 2022 | - | $2.88 B(+222.4%) |
| Dec 2021 | $892.11 M(-66.3%) | $892.11 M(-58.7%) |
| June 2021 | - | $2.16 B(-18.3%) |
| Dec 2020 | $2.65 B(+72.7%) | $2.65 B(+120.9%) |
| June 2020 | - | $1.20 B(-21.8%) |
| Dec 2019 | $1.53 B(+1323.0%) | $1.53 B(+169.2%) |
| June 2019 | - | $569.52 M(+428.7%) |
| Dec 2018 | $107.73 M(-71.6%) | $107.73 M(-48.9%) |
| June 2018 | - | $211.01 M(-44.5%) |
| Dec 2017 | $379.88 M(+93.0%) | $379.88 M(-41.5%) |
| June 2017 | - | $649.86 M(+230.2%) |
| Dec 2016 | $196.81 M(+29.5%) | $196.81 M(+25.1%) |
| June 2016 | - | $157.37 M(+3.5%) |
| Dec 2015 | $152.00 M(-50.5%) | $152.00 M(-42.4%) |
| June 2015 | - | $264.02 M(-13.9%) |
| Dec 2014 | $306.78 M(+29.4%) | $306.78 M(+53.6%) |
| June 2014 | - | $199.78 M(-15.7%) |
| Dec 2013 | $237.13 M(-11.9%) | $237.13 M(+26.5%) |
| June 2013 | - | $187.47 M(-30.4%) |
| Dec 2012 | $269.23 M(+132.4%) | $269.23 M(+77.2%) |
| June 2012 | - | $151.90 M(+31.1%) |
| Dec 2011 | $115.87 M(-19.3%) | $115.87 M(-28.7%) |
| June 2011 | - | $162.50 M(+13.2%) |
| Dec 2010 | $143.54 M(-12.7%) | $143.54 M(-26.3%) |
| June 2010 | - | $194.69 M(+18.4%) |
| Dec 2009 | $164.46 M(+7.9%) | $164.46 M(+0.3%) |
| June 2009 | - | $163.97 M(+7.5%) |
| Dec 2008 | $152.48 M | $152.48 M(-29.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2008 | - | $216.81 M(+14.1%) |
| Dec 2007 | $190.07 M(-28.2%) | $190.07 M(-33.4%) |
| June 2007 | - | $285.32 M(+7.8%) |
| Dec 2006 | $264.58 M(-36.0%) | $264.58 M(+18.8%) |
| June 2006 | - | $222.71 M(-46.1%) |
| Dec 2005 | $413.27 M(+7.9%) | $413.27 M(+35.2%) |
| June 2005 | - | $305.75 M(-20.1%) |
| Dec 2004 | $382.88 M(-21.5%) | $382.88 M(+2.9%) |
| June 2004 | - | $372.17 M(-23.7%) |
| Dec 2003 | $487.82 M(+22.8%) | $487.82 M(+132.1%) |
| June 2003 | - | $210.18 M(-47.1%) |
| Dec 2002 | $397.39 M(-29.6%) | $397.39 M(-22.4%) |
| June 2002 | - | $512.11 M(-9.2%) |
| Dec 2001 | $564.26 M(+39.6%) | $564.26 M(+147.0%) |
| June 2001 | - | $228.49 M(-43.5%) |
| Dec 2000 | $404.20 M(-29.3%) | $404.20 M(-47.2%) |
| June 2000 | - | $765.48 M |
| Dec 1999 | $571.54 M(+91.7%) | - |
| Dec 1998 | $298.20 M(-16.1%) | - |
| Dec 1997 | $355.56 M(+10.2%) | - |
| Dec 1996 | $322.56 M(+19.6%) | - |
| Dec 1995 | $269.60 M(+60.8%) | - |
| Dec 1994 | $167.69 M(+25.4%) | - |
| Dec 1993 | $133.71 M(-15.3%) | - |
| Dec 1992 | $157.92 M(+40.5%) | - |
| Dec 1991 | $112.44 M(+5.8%) | - |
| Dec 1990 | $106.31 M(+23.7%) | - |
| Dec 1989 | $85.94 M(+20.8%) | - |
| Dec 1988 | $71.12 M(+8.7%) | - |
| Dec 1987 | $65.41 M(+124.9%) | - |
| Dec 1986 | $29.09 M(+52.0%) | - |
| Dec 1985 | $19.14 M | - |
FAQ
- What is Rentokil Initial annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Rentokil Initial?
- What is Rentokil Initial annual cash & cash equivalents year-on-year change?
- What is Rentokil Initial quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Rentokil Initial?
- What is Rentokil Initial quarterly cash and cash equivalents year-on-year change?
What is Rentokil Initial annual cash & cash equivalents?
The current annual cash & cash equivalents of RTO is $1.97 B
What is the all time high annual cash & cash equivalents for Rentokil Initial?
Rentokil Initial all-time high annual cash & cash equivalents is $2.65 B
What is Rentokil Initial annual cash & cash equivalents year-on-year change?
Over the past year, RTO annual cash & cash equivalents has changed by -$639.68 M (-24.50%)
What is Rentokil Initial quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RTO is $1.97 B
What is the all time high quarterly cash and cash equivalents for Rentokil Initial?
Rentokil Initial all-time high quarterly cash and cash equivalents is $2.88 B
What is Rentokil Initial quarterly cash and cash equivalents year-on-year change?
Over the past year, RTO quarterly cash and cash equivalents has changed by +$180.76 M (+10.11%)